Inventor
FU JIANMIN
CA58 patents
⚠️ This page may combine multiple inventors who share the name “FU JIANMIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
XENON PHARMACEUTICALS INC
17 patentsUS7935721B2May 3, 2011
Spiro-oxindole compounds and their uses as therapeutic agents
XENON PHARMACEUTICALS INC18 citations92
US7799798B2Sep 21, 2010
Spiroheterocyclic compounds and their uses as therapeutic agents
XENON PHARMACEUTICALS INC26 citations92
US7767677B2Aug 3, 2010
Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
XENON PHARMACEUTICALS INC34 citations92
US7700641B2Apr 20, 2010
Spiro-oxindole compounds and their uses as therapeutic agents
XENON PHARMACEUTICALS INC39 citations92
US7592343B2Sep 22, 2009
Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors
XENON PHARMACEUTICALS INC22 citations92
US7547698B2Jun 16, 2009
Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)
XENON PHARMACEUTICALS INC18 citations84
US9480677B2Nov 1, 2016
Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents
XENON PHARMACEUTICALS INC5 citations83
US8916580B2Dec 23, 2014
Spiro-oxindole compounds and their use as therapeutic agents
XENON PHARMACEUTICALS INC4 citations83
US7777036B2Aug 17, 2010
Heterocyclic derivatives and their use as therapeutic agents
XENON PHARMACEUTICALS INC13 citations83
US9260446B2Feb 16, 2016
Synthetic methods for spiro-oxindole compounds
XENON PHARMACEUTICALS INC4 citations81
US9487535B2Nov 8, 2016
Asymmetric syntheses for spiro-oxindole compounds useful as therapeutic agents
XENON PHARMACEUTICALS INC5 citations73
US9695185B2Jul 4, 2017
Synthetic methods for spiro-oxindole compounds
XENON PHARMACEUTICALS INC3 citations71
US9458178B2Oct 4, 2016
Spiro-oxindole compounds and their use as therapeutic agents
XENON PHARMACEUTICALS INC1 citations61
US8026360B2Sep 27, 2011
Substituted pyridazines as stearoyl-CoA desaturase inhibitors
XENON PHARMACEUTICALS INC3 citations61
US7919496B2Apr 5, 2011
Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-CoA desaturase enzymes
XENON PHARMACEUTICALS INC1 citations52
US7829712B2Nov 9, 2010
Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase
XENON PHARMACEUTICALS INC1 citations52
US7951805B2May 31, 2011
Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
XENON PHARMACEUTICALS INC0 citations41
MERCK SHARP & DOHME
14 patentsUS9777035B2Oct 3, 2017
4′-substituted nucleoside reverse transcriptase inhibitors
MERCK SHARP & DOHME10 citations81
US9808542B2Nov 7, 2017
Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrillary
MERCK SHARP & DOHME7 citations80
US10544130B2Jan 28, 2020
Metallo-beta-lactamase inhibitors
MERCK SHARP & DOHME1 citations73
US10221163B2Mar 5, 2019
Metallo-beta-lactamase inhibitors
MERCK SHARP & DOHME4 citations73
US9988397B2Jun 5, 2018
ERK inhibitors
MERCK SHARP & DOHME2 citations71
US10160762B2Dec 25, 2018
6-alkyl dihydropyrazolopyrimidinone compounds as PDE2 inhibitors
MERCK SHARP & DOHME2 citations70
US10030027B2Jul 24, 2018
Soluble guanylate cyclase stimulators
MERCK SHARP & DOHME3 citations70
US10022461B2Jul 17, 2018
Pyrrolo[2,3-C]pyridines as imaging agents for neurofibrilary tangles
MERCK SHARP & DOHME2 citations70
US10227331B2Mar 12, 2019
Metallo-β-lactamase inhibitors
MERCK SHARP & DOHME1 citations62
US9884048B2Feb 6, 2018
ERK inhibitors
MERCK SHARP & DOHME2 citations59
US10428076B2Oct 1, 2019
Soluble guanylate cyclase stimulators
MERCK SHARP & DOHME0 citations49
US10100064B2Oct 16, 2018
Purine inhibitors of human phosphatidylinositol 3-kinase delta
MERCK SHARP & DOHME1 citations49
US11179389B2Nov 23, 2021
Purine inhibitors of human phosphatidylinositol 3-kinase delta
MERCK SHARP & DOHME0 citations46
US9573913B2Feb 21, 2017
Cathepsin cysteine protease inhibitors
MERCK SHARP & DOHME0 citations40
CHAFEEV MIKHAIL
7 patentsUS8466188B2Jun 18, 2013
Use of spiro-oxindole compounds as therapeutic agents
CHAFEEV MIKHAIL63 citations97
US8883840B2Nov 11, 2014
Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents
CHAFEEV MIKHAIL63 citations96
US8106087B2Jan 31, 2012
Spiro-oxindole compounds and their uses as therapeutic agents
CHAFEEV MIKHAIL19 citations92
US8450358B2May 28, 2013
Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents
CHAFEEV MIKHAIL17 citations91
US8263606B2Sep 11, 2012
Spiro-oxindole compounds and their use as therapeutic agents
CHAFEEV MIKHAIL16 citations91
US8101647B2Jan 24, 2012
Spiro-oxindole compounds and their use as therapeutic agents
CHAFEEV MIKHAIL35 citations91
US8415370B2Apr 9, 2013
Spiro-oxindole compounds and their uses as therapeutic agents
CHAFEEV MIKHAIL10 citations82
DALES NATALIE
6 patentsUS8258160B2Sep 4, 2012
SCD1 inhibitors triazole and tetrazole compounds
DALES NATALIE11 citations82
US8063084B2Nov 22, 2011
Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid levels
DALES NATALIE6 citations72
US8501746B2Aug 6, 2013
Organic compounds
DALES NATALIE3 citations61
US9187426B2Nov 17, 2015
Organic compounds
DALES NATALIE0 citations51
US8293768B2Oct 23, 2012
Organic compounds
DALES NATALIE0 citations51
US8236835B2Aug 7, 2012
Heterocyclic inhibitors of stearoyl-CoA desaturase
DALES NATALIE0 citations41
CADIEUX JEAN-JACQUES
2 patentsNOVARTIS AG
1 patentFU JIANMIN
1 patentXRAD THERAPEUTICS INC
1 patentCHOWDHURY SULTAN
1 patentShowing the top 50 of 58 patents by PatentIndex Score.